Application Sponsors
ANDA 084113 | UPSHER SMITH LABS | |
Marketing Status
Application Products
001 | TABLET;ORAL | 50MG | 0 | CHLORPROMAZINE HYDROCHLORIDE | CHLORPROMAZINE HYDROCHLORIDE |
FDA Submissions
| ORIG | 1 | AP | 1974-07-09 | |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 63 | AP | 1982-04-26 | |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 65 | AP | 1984-04-10 | |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 69 | AP | 1985-02-01 | |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 70 | AP | 1986-03-11 | |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 72 | AP | 1986-07-10 | |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 73 | AP | 1986-07-10 | |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 74 | AP | 1987-03-12 | |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 75 | AP | 1987-12-07 | |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 76 | AP | 1987-12-07 | |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 79 | AP | 1988-04-14 | |
LABELING; Labeling | SUPPL | 80 | AP | 1988-03-08 | |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 81 | AP | 1988-07-08 | |
LABELING; Labeling | SUPPL | 82 | AP | 1988-04-26 | |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 83 | AP | 1989-02-14 | |
LABELING; Labeling | SUPPL | 84 | AP | 1990-11-29 | |
LABELING; Labeling | SUPPL | 85 | AP | 1991-12-31 | |
LABELING; Labeling | SUPPL | 86 | AP | 1992-09-16 | |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 87 | AP | 1996-02-05 | |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 88 | AP | 1999-03-22 | |
LABELING; Labeling | SUPPL | 89 | AP | 1999-03-22 | |
LABELING; Labeling | SUPPL | 90 | AP | 2002-11-25 | |
LABELING; Labeling | SUPPL | 105 | AP | 2008-11-19 | |
LABELING; Labeling | SUPPL | 108 | AP | 2009-08-24 | |
LABELING; Labeling | SUPPL | 111 | AP | 2010-12-03 | |
LABELING; Labeling | SUPPL | 114 | AP | 2011-09-13 | |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 118 | AP | 2016-08-29 | UNKNOWN |
LABELING; Labeling | SUPPL | 119 | AP | 2017-02-23 | STANDARD |
LABELING; Labeling | SUPPL | 122 | AP | 2020-02-05 | STANDARD |
Submissions Property Types
SUPPL | 63 | Null | 0 |
SUPPL | 65 | Null | 0 |
SUPPL | 69 | Null | 0 |
SUPPL | 70 | Null | 0 |
SUPPL | 72 | Null | 0 |
SUPPL | 73 | Null | 0 |
SUPPL | 74 | Null | 0 |
SUPPL | 75 | Null | 0 |
SUPPL | 76 | Null | 0 |
SUPPL | 79 | Null | 0 |
SUPPL | 81 | Null | 0 |
SUPPL | 83 | Null | 0 |
SUPPL | 87 | Null | 0 |
SUPPL | 88 | Null | 0 |
SUPPL | 108 | Null | 7 |
SUPPL | 111 | Null | 7 |
SUPPL | 114 | Null | 15 |
SUPPL | 118 | Null | 7 |
SUPPL | 119 | Null | 7 |
SUPPL | 122 | Null | 7 |
TE Codes
CDER Filings
UPSHER SMITH LABS
cder:Array
(
[0] => Array
(
[ApplNo] => 84113
[companyName] => UPSHER SMITH LABS
[docInserts] => ["",""]
[products] => [{"drugName":"CHLORPROMAZINE HYDROCHLORIDE","activeIngredients":"CHLORPROMAZINE HYDROCHLORIDE","strength":"50MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"CHLORPROMAZINE HYDROCHLORIDE","submission":"CHLORPROMAZINE HYDROCHLORIDE","actionType":"50MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
[supplements] =>
[actionDate] => 1969-12-31
)
)